Stem cell therapy: A paradigm shift in breast cancer treatment

doi:10.4252/wjsc.v13.i7.841

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7436)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

426

WORD

153

HTML

5238

Figures (1-6)

226

Tables (1-2)

254

Sum=6297

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

406

Download

733

Sum=1139

Jul 26, 2021 (publication date) through Sep 4, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Jul 26, 2021; 13(7): 841-860
Published online Jul 26, 2021. doi: 10.4252/wjsc.v13.i7.841

Full Size Figure Download Figure

Figure 5 Pharmacological targeting of breast cancer stem cells. Insights from preclinical and clinical studies have shown that various small molecular inhibitors and antibodies against the effectors of the aberrantly expressed pathways can be targeted to downregulate the stemness and altered phenotype of breast cancer stem cells. EMT: Epithelial mesenchymal transitions; CDK: Cyclin dependent kinase; GSI: γ-secretase inhibitors; PI3K: Phosphatidylinositol 3-kinase; PTK: Protein tyrosine kinase.

Citation: Khan S, Suryavanshi M, Kaur J, Nayak D, Khurana A, Manchanda RK, Tandon C, Tandon S. Stem cell therapy: A paradigm shift in breast cancer treatment. World J Stem Cells 2021; 13(7): 841-860
URL: https://www.wjgnet.com/1948-0210/full/v13/i7/841.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i7.841